Wellbutrin Drug Classification
Wellbutrin (bupropion) is an aminoketone antidepressant that is chemically unrelated to tricyclic, tetracyclic, selective serotonin reuptake inhibitor (SSRI), or other known antidepressant agents. 1
Pharmacologic Class Details
Bupropion belongs to the aminoketone class of antidepressants, with a chemical structure closely resembling diethylpropion and related to phenylethylamines 1. This classification distinguishes it from all other major antidepressant categories.
Mechanism of Action
The drug functions primarily as a norepinephrine-dopamine reuptake inhibitor (NDRI) 2. Specifically:
- Inhibits dopamine and norepinephrine reuptake in the central nervous system
- Acts as an inhibitor of nicotinic acetylcholinergic receptors 2
- Does not inhibit serotonin reuptake, making it unique among commonly prescribed antidepressants 1
- Does not inhibit monoamine oxidase 1
Clinical Classification Context
While bupropion is classified as an atypical or second-generation antidepressant 3, 4, it stands alone in its class. The FDA-approved drug label explicitly states it is "chemically unrelated to tricyclic, tetracyclic, selective serotonin reuptake inhibitor, or other known antidepressant agents" 1.
FDA-Approved Indications
Bupropion carries FDA approval for:
- Major depressive disorder (as Wellbutrin) 5, 1
- Smoking cessation (as Zyban) 2
- Seasonal affective disorder 6
The drug is also used in combination formulations (naltrexone-bupropion) for obesity management 7, though this represents a different branded product.
Key Distinguishing Features
Bupropion is the only antidepressant available in the United States with no appreciable activity on serotonin concentrations, making it particularly useful for patients who cannot tolerate serotonergic side effects like sexual dysfunction 4. Its dopaminergic and noradrenergic activity profile sets it apart from SSRIs, SNRIs, tricyclics, and MAO inhibitors.